Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Clinical Immunology
Published in: Journal of Clinical Immunology 7/2018

01-10-2018 | Letter to Editor

Chronic Aichi Virus Infection in a Patient with X-Linked Agammaglobulinemia

Authors: Giorgia Bucciol, Leen Moens, Kathryn Payne, Elke Wollants, Djalila Mekahli, Elena Levtchenko, François Vermeulen, Thomas Tousseyn, Paul Gray, Cindy S. Ma, Stuart G. Tangye, Marc Van Ranst, Julianne R. Brown, Judy Breuer, Isabelle Meyts

Published in: Journal of Clinical Immunology | Issue 7/2018

Login to get access

Excerpt

To the Editor, …
Appendix
Available only for authorised users
Literature
1.
Conley ME, Rohrer J, Minegishi Y. X-linked agammaglobulinemia. Clin Rev Allergy Immunol. 2000 Oct 1;19(2):183–204.CrossRef
2.
Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C, Ochs HD, Bonilla FA, Paris K, et al. Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol. 2014 Aug 1;34(6):627–32.CrossRef
3.
Bearden D, Collett M, Quan PL, Costa-Carvalho BT, Sullivan KE. Enteroviruses in X-linked agammaglobulinemia: update on epidemiology and therapy. J Allergy Clin Immunol Pract. 2016 Dec;4(6):1059–65.CrossRef
4.
Frange P, Touzot F, Debré M, Héritier S, Leruez-Ville M, Cros G, et al. Prevalence and clinical impact of norovirus fecal shedding in children with inherited immune deficiencies. J Infect Dis. 2012 Oct 15;206(8):1269–74.CrossRef
5.
Kempf B, Edgar JD, Mc Caughey C, Devlin LA. Nitazoxanide is an ineffective treatment of chronic norovirus in patients with X-linked agammaglobulinemia and may yield false-negative polymerase chain reaction findings in stool specimens. J Infect Dis. 2017 Feb 1;215(3):486–7.CrossRef
6.
Brown L-AK, Clark I, Brown JR, Breuer J, Lowe DM. Norovirus infection in primary immune deficiency. Rev Med Virol. 2017 Mar 8;27(3):e1926.CrossRef
7.
Frémond M-L, Pérot P, Muth E, Cros G, Dumarest M, Mahlaoui N, et al. Next-generation sequencing for diagnosis and tailored therapy: a case report of astrovirus-associated progressive encephalitis. J Pediatr Infect Dis Soc. 2015 Sep 1;4(3):e53–7.CrossRef
8.
Wilson MR, Suan D, Duggins A, Schubert RD, Khan LM, Sample HA, et al. A novel cause of chronic viral meningoencephalitis: cache Valley virus. Ann Neurol. 2017 Jun 19;82(1):105–14.CrossRef
9.
Martini H, Enright V, Perro M, Workman S, Birmelin J, Giorda E, et al. Importance of B cell co-stimulation in CD4+ T cell differentiation: X-linked agammaglobulinaemia, a human model. Clin Exp Immunol. 2011 Apr 13;164(3):381–7.CrossRef
10.
Ma CS, Wong N, Rao G, Avery DT, Torpy J, Hambridge T, et al. Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies. J Allergy Clin Immunol. 2015 Oct 1;136(4):993–1006.e1.CrossRef
11.
Kawada J, Okuno Y, Torii Y, Okada R, Hayano S, Ando S, et al. Identification of viruses in cases of pediatric acute encephalitis and encephalopathy using next-generation sequencing. Sci Rep. 2016 Sep 14;6:33452.CrossRef
12.
Wilson MR, Naccache SN, Samayoa E, Biagtan M, Bashir H, Yu G, et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med. 2014 Jun 19;370(25):2408–17.CrossRef
13.
Yamashita T, Sakae K, Tsuzuki H, Suzuki Y, Ishikawa N, Takeda N, et al. Complete nucleotide sequence and genetic organization of Aichi virus, a distinct member of the Picornaviridae associated with acute gastroenteritis in humans. J Virol. 1998 Oct 1;72(10):8408–12.PubMedPubMedCentral
14.
Kitajima M, Gerba CP. Aichi virus 1: environmental occurrence and behavior. Pathogens. 2015 May 19;4(2):256–68.CrossRef
15.
Yamashita T, Sakae K, Ishihara Y, Isomura S, Utagawa E. Prevalence of newly isolated, cytopathic small round virus (Aichi strain) in Japan. J Clin Microbiol. 1993 Nov 1;31(11):2938–43.PubMedPubMedCentral
16.
Goyer M, Aho L-S, Bour J-B, Ambert-Balay K, Pothier P. Seroprevalence distribution of Aichi virus among a French population in 2006–2007. Arch Virol. 2008 Jun 1;153(6):1171–4.CrossRef
17.
Ribes JM, Montava R, Téllez-Castillo CJ, Fernández-Jiménez M, Buesa J. Seroprevalence of Aichi virus in a Spanish population from 2007 to 2008. Clin Vaccine Immunol. 2010 Apr 1;17(4):545–9.CrossRef
18.
Sdiri-Loulizi K, Hassine M, Bour J-B, Ambert-Balay K, Mastouri M, Aho L-S, et al. Aichi virus IgG seroprevalence in Tunisia parallels genomic detection and clinical presentation in children with gastroenteritis. Clin Vaccine Immunol. 2010 Jul 1;17(7):1111–6.CrossRef
19.
Oh D-Y, Silva PA, Hauroeder B, Diedrich S, Cardoso DDP, Schreier E. Molecular characterization of the first Aichi viruses isolated in Europe and in South America. Arch Virol. 2006 Jun 1;151(6):1199–206.CrossRef
20.
Portes SAR, de Mello Volotao E, Rose TL, Rocha MS. Trindade Pinheiro Xavier M da P, de Assis RM, et al. Aichi virus positivity in HIV-1 seropositive children hospitalized with diarrheal disease. Curr HIV Res. 2015;13(4):325–31.CrossRef
21.
Oude Munnink BB, Canuti M, Deijs M, de Vries M, Jebbink MF, Rebers S, et al. Unexplained diarrhoea in HIV-1 infected individuals. BMC Infect Dis. 2014 Jan 13;14:22.CrossRef
22.
Jongco AM, Gough JD, Sarnataro K, Rosenthal DW, Moreau J, Ponda P, et al. X-linked agammaglobulinemia presenting as polymicrobial pneumonia, including Pneumocystis jirovecii. Ann Allergy Asthma Immunol. 2014 Jan 1;112(1):74–75.e2.CrossRef
23.
Gofshteyn J, Cárdenas AM, Bearden D. Treatment of chronic enterovirus encephalitis with fluoxetine in a patient with X-linked agammaglobulinemia. Pediatr Neurol. 2016 Nov 1;64:94–8.CrossRef
24.
Engelen MA, Gunia S, Stypmann J. Elimination of norovirus in a chronic carrier under immunosuppression after heart transplantation – effect of everolimus. Transpl Int. 2011;24(11):e102–3.CrossRef
25.
Andrassy J, Hoffmann VS, Rentsch M, Stangl M, Habicht A, Meiser B, et al. Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor–based immunosuppression? A systematic review and meta-analysis. Transplantation. 2012 Dec 27;94(12):1208.CrossRef
26.
Blanco NB, Kuonen R, Bellini C, Manuel O, Estrade C, Mazza-Stalder J, et al. Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient. Transpl Infect Dis. 2011;13(2):213–5.CrossRef
27.
Xu F, Zhao X, Hu S, Li J, Yin L, Mei S, et al. Amphotericin B inhibits enterovirus 71 replication by impeding viral entry. Sci Rep. 2016 Sep 9;6:33150.CrossRef
28.
29.
Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015 Aug;15(8):486–99.CrossRef
30.
Yamamoto T, Price DA, Casazza JP, Ferrari G, Nason M, Chattopadhyay PK, et al. Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection. Blood. 2011 May 5;117(18):4805–15.CrossRef
31.
Randall KL, Chan SS-Y, Ma CS, Fung I, Mei Y, Yabas M, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011 Oct 24;208(11):2305–20.CrossRef
Metadata
Title
Chronic Aichi Virus Infection in a Patient with X-Linked Agammaglobulinemia
Authors
Giorgia Bucciol
Leen Moens
Kathryn Payne
Elke Wollants
Djalila Mekahli
Elena Levtchenko
François Vermeulen
Thomas Tousseyn
Paul Gray
Cindy S. Ma
Stuart G. Tangye
Marc Van Ranst
Julianne R. Brown
Judy Breuer
Isabelle Meyts
Publication date
01-10-2018
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 7/2018
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-018-0558-z

Other articles of this Issue 7/2018

Journal of Clinical Immunology 7/2018 Go to the issue

Original Article

Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center

Letter to Editor

XL-EDA-ID Presenting with Congenital Duodenal Atresia and Perforations

Original Article

High Rates of Community and Hospital Acquired Infections in Patients with Cellular Immunodeficiencies

Original Article

Newborn Screening for Severe Combined Immunodeficiency: Analytic and Clinical Performance of the T Cell Receptor Excision Circle Assay in France (DEPISTREC Study)

Letter to Editor

Pseudo-Sarcoidosis Revealing MonoMAC Syndrome

Letter to Editor

Newborn Screening for IKBKB Deficiency in Manitoba, Using Genetic Mutation Analysis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits